Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study
Paul Karpecki, Michael DePaolis, Judy A. Hunter, Eric M. White, Lee Rigel, Lynne S. Brunner, Dale W. Usner, Michael R. Paterno, Timothy L. ComstockVolume:
31
Year:
2009
Language:
english
Pages:
13
DOI:
10.1016/j.clinthera.2009.03.010
File:
PDF, 1.79 MB
english, 2009